The Joint (JYNT)
(Delayed Data from NSDQ)
$15.93 USD
-0.49 (-2.98%)
Updated May 28, 2024 04:00 PM ET
After-Market: $15.96 +0.03 (0.19%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
Brokerage Reports
The Joint Corp. [JYNT]
Reports for Purchase
Showing records 141 - 149 ( 149 total )
Company: The Joint Corp.
Industry: Medical - HMOs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: The Joint Corp.
Industry: Medical - HMOs
Acquired Regional Developer and four stores, start of corporate store process
Provider: Feltl & Company
Analyst: RYSTROM B
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
3Q:14 reported, modest changes to 4Q, reiterating STRONG BUY and PT of $12.45
Provider: Feltl & Company
Analyst: RYSTROM B
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Shift to corporate store model could drive exceptional shareholder returns; PT $12.45
Provider: Feltl & Company
Analyst: RYSTROM B
Company: The Joint Corp.
Industry: Medical - HMOs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.